ADJUPANRIX

This brand name is authorized in Austria, Estonia, Ireland, Lithuania, Poland, Singapore

Active ingredients

The drug ADJUPANRIX contains one active pharmaceutical ingredient (API):

1 A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)
Read about Influenza, inactivated, split virus

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
ADJUPANRIX Emulsion for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J07BB02 Influenza, purified antigen J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1451180
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1051384
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100308539
Country: SG Health Sciences Authority Identifier(s): 15239P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.